BioSolution announced a collaboration with global life‑science company Merck Life Science to introduce an animal‑alternative testing research solution that integrates 3D human tissue models with precise analytical technology.
The joint booth will be presented at the World Pharma·Bio·Health Functional Industry Exhibition (CPHI Korea 2026) held from May 25‑27 at COEX, Seoul. The exhibitors will demonstrate a complete workflow that links both technologies into a single research process, enabling the use of the combined platform for animal‑free testing, a growing demand in new‑drug and cosmetics development.
Research & ReportsSep 6, 2026•1 min read
BioSolution and Merck Life Science Unveil Animal‑Free Testing Solution at CPHI Korea 2026
BioSolution partnered with Merck Life Science to showcase a combined 3D human tissue model and precision analysis workflow for animal‑alternative testing at CPHI Korea 2026.
Compiled by the PharmaCountry team · Source: KPA News
Topics:#animal testing alternatives#3D tissue models#precision analysis#pharma research#cosmetics#CPHI Korea
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating